AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice
(ID 37)
Calendar Export
Impact of CDK4/6 Inhibitors as Adjuvant Therapy in HR-positive, HER2-negative Early Breast Cancer: A Focus on Recent Evidence
(ID 438)
Lecture Time
12:30 - 12:30
Speakers
All Speakers
(na, Swaziland)
Authors
All Speakers
(na, Swaziland)
Session Name
AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice
(ID 37)
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
12:30 - 13:30